会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • MEDICAL DEVICE SYSTEM WITH RELAYING MODULE FOR TREATMENT OF NERVOUS SYSTEM DISORDERS
    • 具有用于治疗神经系统疾病的继电器模块的医疗装置系统
    • WO2004034997A3
    • 2004-10-14
    • PCT/US0332867
    • 2003-10-15
    • MEDTRONIC INCRISE MARK TDONDERS ADRIANUS PSCHAFFNER SCOTT F
    • RISE MARK TDONDERS ADRIANUS PSCHAFFNER SCOTT F
    • A61B17/52A61F7/00A61N1/00A61N1/08A61N1/32A61N1/36A61N1/372A61N2/00A61L9/22A61N1/01
    • A61N2/00A61N1/08A61N1/32A61N1/36082A61N1/36135A61N1/37229A61N1/37252
    • Apparatus and method facilitates communications between an implanted component (1405) and an external component (950) of a medical device system through a relaying module (1415). The medical device system provides treatment to a patient for a nervous system disorder. The relaying module (1415) (which may be worn by the patient) provides telemetry channels between the implanted component (1405) and the relaying module (1415) and between the telemetry module (1421) and the external component (950). With an implantable configuration the implanted component (1405) comprises a monitoring (20) componet, a treatment therapy unit (30), an interfacing unit (22), and a processing unit (24), and the external component comprises a programmer (23). With a hybrid configuration the implanted component (953) comprises a monitoring element (952), a treatment delivery unit (955), and an interfacing unit (951), and the external component comprises a processing unit (950). With an external configuration, the implanted component comprises a monitoring element (101) and a treatment delivery unit (107), and the external component comprises an interfacing unit (103) and a processing unit (105).
    • 装置和方法通过中继模块(1415)有助于植入部件(1405)和医疗装置系统的外部部件(950)之间的通信。 医疗装置系统为患者提供神经系统障碍的治疗。 中继模块(1415)(其可以由患者佩戴)在植入部件(1405)和中继模块(1415)之间以及遥测模块(1421)和外部组件(950)之间提供遥测通道。 通过植入式构造,植入部件(1405)包括监控(20)部件,治疗治疗单元(30),接口单元(22)和处理单元(24),并且外部部件包括编程器(23 )。 通过混合配置,植入部件(953)包括监视元件(952),处理传送单元(955)和接口单元(951),并且外部部件包括处理单元(950)。 利用外部配置,植入部件包括监视元件(101)和处理传送单元(107),并且外部部件包括接口单元(103)和处理单元(105)。
    • 7. 发明专利
    • Implantable therapy system
    • AU2014201907A1
    • 2014-04-17
    • AU2014201907
    • 2014-04-02
    • ENTEROMEDICS INC
    • DONDERS ADRIANUS PWEIJAND KOEN JLAMBERT SCOTT ANTHONYSPAR GREGORY PATSTULTZ MARK RAYMONDVALLAPUREDDY VINEELLAUGHLIN JOHN CHARLES
    • A61N1/36A61N1/372
    • Abstract A system for applying therapy to an internal anatomical feature of a body of a patient comprising, an external component including an external antenna configured to be placed 5 above a skin layer of a patient, the external component including a memory configured to store therapy programs and therapy schedules, the external component also including a user interface configured to receive input from a user and to display output to the user, the input including a selection of one of the therapy programs and one of the therapy schedules and an implantable component for placement in the body of the patient beneath 10 the skin layer, the implantable component including an implanted antenna configured to communicate with the external antenna across the skin layer through radiofrequency communication, the implantable component being configured to receive the selected therapy program and the selected therapy schedule from the external component via the external and implanted antennas, the implantable component being adapted to be 15 selectively configured into one of a training mode, a placebo mode, and a delivery mode, the implantable component being configured to apply therapy to the internal anatomical feature in accordance with the selected therapy program and the selected therapy schedule when configured in the delivery mode, and the implantable component being configured to refrain from generating electrical therapy signals when configured in the 20 training mode, and the implantable component being configured to supply therapy signals to a resistor located within the implantable component to drain an internal power source of the implantable component when configured in the placebo mode, wherein an external charger interacts with the patient as if therapy is being applied when the therapy signals are applied to the resistor during the placebo mode. 52587751 (GHMalters) P82937AU I
    • 10. 发明专利
    • Implantable therapy system
    • AU2014201907B2
    • 2015-06-18
    • AU2014201907
    • 2014-04-02
    • ENTEROMEDICS INC
    • DONDERS ADRIANUS PWEIJAND KOEN JLAMBERT SCOTT ANTHONYSPAR GREGORY PATSTULTZ MARK RAYMONDVALLAPUREDDY VINEELLAUGHLIN JOHN CHARLES
    • A61N1/36A61N1/372
    • Abstract A system for applying therapy to an internal anatomical feature of a body of a patient comprising, an external component including an external antenna configured to be placed 5 above a skin layer of a patient, the external component including a memory configured to store therapy programs and therapy schedules, the external component also including a user interface configured to receive input from a user and to display output to the user, the input including a selection of one of the therapy programs and one of the therapy schedules and an implantable component for placement in the body of the patient beneath 10 the skin layer, the implantable component including an implanted antenna configured to communicate with the external antenna across the skin layer through radiofrequency communication, the implantable component being configured to receive the selected therapy program and the selected therapy schedule from the external component via the external and implanted antennas, the implantable component being adapted to be 15 selectively configured into one of a training mode, a placebo mode, and a delivery mode, the implantable component being configured to apply therapy to the internal anatomical feature in accordance with the selected therapy program and the selected therapy schedule when configured in the delivery mode, and the implantable component being configured to refrain from generating electrical therapy signals when configured in the 20 training mode, and the implantable component being configured to supply therapy signals to a resistor located within the implantable component to drain an internal power source of the implantable component when configured in the placebo mode, wherein an external charger interacts with the patient as if therapy is being applied when the therapy signals are applied to the resistor during the placebo mode. 52587751 (GHMalters) P82937AU I